IME — Imagin Medical Income Statement
0.000.00%
Last trade - 00:00
HealthcareSpeculativeMicro Cap
2018 September 30th | 2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 8.01 | 4.55 | 4.39 | 11.4 | 2.51 |
Operating Profit | -8.01 | -4.55 | -4.39 | -11.4 | -2.51 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -7.96 | -4.46 | -4.38 | -11.5 | -2.49 |
Net Income After Taxes | -7.96 | -4.46 | -4.38 | -11.5 | -2.49 |
Net Income Before Extraordinary Items | |||||
Net Income | -7.96 | -4.46 | -4.38 | -11.5 | -2.49 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -7.96 | -4.46 | -4.38 | -11.5 | -2.49 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.48 | -0.642 | -0.528 | -0.433 | -0.353 |